1. GeneDx management to speak at Jefferies Healthcare Conference on June 4, 2025. 2. Participation at Goldman Sachs Healthcare Conference on June 9, 2025. 3. Live webcasts of presentations available on GeneDx's investor relations site.
Participating in high-profile conferences can enhance visibility and attract investors. A similar past event led to positive stock movements for biotech firms.
The announcement of conference participation signals ongoing investor engagement and confidence, likely affecting market perception.
Investor sentiment may rapidly shift due to upcoming conference discussions. Historical conference participation typically reflects immediate market responses.
GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Live and archived webcasts of the presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.
About GeneDx
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.